Animal models

$189,580P01FY2009NSNIH

Washington University, Saint Louis MO

Investigators

Linked publications & trials

Paper 31818229 Paper 28159432 Paper 26712324 Paper 26484787 Paper 24414067 Paper 24017967 Paper 23892229 Paper 23362079 Paper 23043544 Paper 23038755 Paper 23015448 Paper 22664962 Paper 22539346 Paper 22521466 Paper 22354966 Paper 22340958 Paper 22314269 Paper 22302006 Paper 22201533 Paper 21807360 Paper 21532579 Paper 21437933 Paper 21344532 Paper 21283729 Paper 21248122 Paper 21236346 Paper 21197121 Paper 20621643 Paper 20554841 Paper 20461560 Paper 20394760 Paper 20382858 Paper 20347873 Paper 20132289 Paper 20016651 Paper 20005821 Paper 19910533 Paper 19896473 Paper 19710322 Paper 19679070 Paper 19644058 Paper 19521348 Paper 19476541 Paper 19393318 Paper 19364913 Paper 19355934 Paper 19264960 Paper 19109498 Paper 19074028 Paper 19064794 Paper 19022347 Paper 18984964 Paper 18703769 Paper 18456655 Paper 18354017 Paper 18309923 Paper 17978027 Paper 17962594 Paper 17525383 Paper 17448638 Paper 17429000 Paper 17376527 Paper 17368446 Paper 17071096 Paper 16828292 Paper 16240365 Paper 16158420 Paper 16046277 Paper 15925103 Paper 15846801 Paper 15668737 Paper 15056459 Paper 14727960 Paper 14643378 Paper 12679386 Paper 12677023 Paper 12511771 Paper 12435430 Paper 12435425 Paper 12401332 Paper 12364740 Paper 12079403 Paper 11876769 Paper 11640900 Paper 11522957 Paper 11517250 Paper 11404409 Paper 11264313 Paper 11060708 Paper 11018104 Paper 10995780

Abstract

The Animal Model Core will provide technical support and conduct in vivo experiments employing rodent stroke models proposed in Projects 1-3 in this program project (PPG). The main functions of the animal core can be divided into three aims: (1) To maintain the adult focal ischemia model in mice for in vivo studies, and to provide brains subjected to focal ischemia for biochemical, immunohistochemical, and/or morphological analysis.;(2) To implement and execute in vivo experimental protocols proposed by PPG investigators, including pharmacological delivery of drugs, delivery of virus for gene transfer experiments, and physiological monitoring before, during, and after ischemia;and (3) To assist and/or carry out measures of outcome including infarct volume, cerebral blood flow, blood-brain-barrier (BBB) function, and leukocyte adhesion. RELEVANCE TO PUBLIC HEALTH: The Animal Model Core will support the projects in this PPG by enabling investigators to test hypotheses generated by cell culture experiments in animal models of ischemic stroke. In addition the focal ischemia model may be used to test potential therapeutic agents in preclinical studies, prior to trials in man.

View original record on NIH RePORTER →